A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer-Reference-Cited by-同舟云学术

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

Published:2006-12 Issue:1 Volume:6 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Friess Helmut,Langrehr Jan M,Oettle Helmut,Raedle Jochen,Niedergethmann Marco,Dittrich Christian,Hossfeld Dieter K,Stöger Herbert,Neyns Bart,Herzog Peter,Piedbois Pascal,Dobrowolski Frank,Scheithauer Werner,Hawkins Robert,Katz Frieder,Balcke Peter,Vermorken Jan,van Belle Simon,Davidson Neville,Esteve Albert Abad,Castellano Daniel,Kleeff Jörg,Tempia-Caliera Adrien A,Kovar Andreas,Nippgen Johannes

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-6-285/fulltext.html

Reference44 articles.

1. Eskens FA, Dumez H, Hoekstra R, Perschl A, Brindley C, Bottcher S, et al: Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur J Cancer. 2003, 39: 917-926. 10.1016/S0959-8049(03)00057-1.

2. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer. 1996, 32A: 2423-2429. 10.1016/S0959-8049(96)00381-4.

3. Brooks PC: Role of integrins in angiogenesis. Eur J Cancer. 1996, 32A: 2423-2429. 10.1016/S0959-8049(96)00381-4.

4. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994, 264: 569-571. 10.1126/science.7512751.

5. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995, 270: 1500-1502. 10.1126/science.270.5241.1500.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

2. Perspective chapter: Imaging of Biological Activity as a Novel Diagnostic Test for Early Melanoma Detection;Skin Cancer - Past, Present and Future [Working Title];2024-08-05

3. TGF-β signaling in health, disease and therapeutics;Signal Transduction and Targeted Therapy;2024-03-22

4. Effect of Annealing on Visible-Bubble Formation and Stability Profiles of Freeze-Dried High Concentration Omalizumab Formulations;Molecular Pharmaceutics;2024-03-02

5. Study on the application value of fluorescent laparoscopy in pancreatic tumor surgery;Gland Surgery;2023-10